A client presents for treatment of infection. Recently, the client has been diagnosed with tendonitis. Which antibiotic drug class should be avoided in this client?

Introduction: Fluoroquinolones are broad-spectrum bactericidal agents that inhibit DNA gyrase, but they are associated with rare but severe musculoskeletal toxicities. The risk of tendon rupture, particularly the Achilles tendon, is significantly higher in patients with pre-existing tendon pathology or those concurrently using systemic corticosteroids or of advanced age. A. Fluoroquinolones, such as ciprofloxacin and levofloxacin, carry a Black Box Warning for increased risk of tendonitis and tendon rupture. In a patient already experiencing tendon inflammation, the administration of this drug class is contraindicated or highly discouraged due to the risk of permanent musculoskeletal damage and functional impairment. B. Aminoglycosides are primarily associated with nephrotoxicity and ototoxicity due to their accumulation in renal and inner ear tissues. They do not possess a known pharmacological mechanism that damages connective tissue or exacerbates tendonitis, making them a safer choice from a musculoskeletal perspective if the infection is susceptible. C. Cephalosporins are beta-lactam antibiotics that interfere with bacterial cell wall synthesis. They have a relatively high safety profile regarding the musculoskeletal system and are not associated with tendon damage. They would be appropriate for treating infections in a patient with tendonitis, provided there are no allergies. D. Penicillins are widely used antibiotics that target gram-positive and some gram-negative organisms without affecting the structural integrity of human tendons. There is no clinical evidence suggesting that penicillins worsen tendonitis or increase the risk of tendon rupture, making them a suitable alternative for this specific patient.